Literature DB >> 31199895

The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors.

João P Lopes1, Anna Pliássova2, Rodrigo A Cunha3.   

Abstract

Caffeine is the most consumed psychoactive drug worldwide and its intake in moderate amounts prevents neurodegenerative disorders. However, the molecular targets of caffeine to modulate activity in brain circuits are ill-defined. By electrophysiologically recording synaptic transmission and plasticity in Schaffer fibers-CA1 pyramid synapses of mouse hippocampal slices, we characterized the impact of caffeine using a concentration reached in the brain parenchyma upon moderate caffeine consumption. Caffeine (50 µM) facilitated synaptic transmission by 40%, while decreasing paired-pulse facilitation, and also decreased by 35% the amplitude of long-term potentiation (LTP). Clearance of extracellular adenosine with adenosine deaminase (2 U/mL) blunted all the effects of caffeine on synaptic transmission and plasticity. The A1R antagonist DPCPX (100 nM) only eliminated caffeine-induced facilitation of synaptic transmission while not affecting caffeine-induced depression of LTP; conversely, the genetic (using A2AR knockout mice) or the pharmacological blockade (with SCH58261, 50 nM) of A2AR eliminated the effect of caffeine on LTP while not affecting caffeine-induced facilitation of synaptic transmission. Finally, blockade of GABAA or of ryanodine receptors with bicuculline (10 μM) or dantrolene (10 μM), respectively, did not affect the ability of caffeine to alter synaptic transmission or plasticity. These results show that the effects of caffeine on synaptic transmission and plasticity in the hippocampus are selectively mediated by antagonizing adenosine receptors, where A1R are responsible for the impact of caffeine on synaptic transmission and A2AR regulate the impact of caffeine on LTP.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Adenosine receptors; Caffeine; Hippocampus; Long-term potentiation; Neuromodulation

Mesh:

Substances:

Year:  2019        PMID: 31199895     DOI: 10.1016/j.bcp.2019.06.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

1.  Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices.

Authors:  Mara Yone D Fernandes; Fernando Dobrachinski; Henrique B Silva; João Pedro Lopes; Francisco Q Gonçalves; Felix A A Soares; Lisiane O Porciúncula; Geanne M Andrade; Rodrigo A Cunha; Angelo R Tomé
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

2.  Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice.

Authors:  Martina Stazi; Silvia Zampar; Madeleine Nadolny; Luca Büschgens; Thomas Meyer; Oliver Wirths
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-09       Impact factor: 5.270

Review 3.  Parkinson's Disease: A Multisystem Disorder.

Authors:  Helena Nunes Costa; Ana Raquel Esteves; Nuno Empadinhas; Sandra Morais Cardoso
Journal:  Neurosci Bull       Date:  2022-08-22       Impact factor: 5.271

4.  The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors.

Authors:  Pedro Valada; Sonja Hinz; Christin Vielmuth; Cátia R Lopes; Rodrigo A Cunha; Christa E Müller; João Pedro Lopes
Journal:  Purinergic Signal       Date:  2022-09-26       Impact factor: 3.950

5.  Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington's Disease.

Authors:  Jannis Achenbach; Andreas Matusch; David Elmenhorst; Andreas Bauer; Carsten Saft
Journal:  Biomedicines       Date:  2022-05-27

6.  Caffeine has a dual influence on NMDA receptor-mediated glutamatergic transmission at the hippocampus.

Authors:  Robertta S Martins; Diogo M Rombo; Joana Gonçalves-Ribeiro; Carlos Meneses; Vladimir P P Borges-Martins; Joaquim A Ribeiro; Sandra H Vaz; Regina C C Kubrusly; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2020-10-06       Impact factor: 3.765

Review 7.  Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.

Authors:  R Brito; K C Calaza; D Pereira-Figueiredo; A A Nascimento; M C Cunha-Rodrigues
Journal:  Cell Mol Neurobiol       Date:  2021-03-17       Impact factor: 5.046

Review 8.  Adenosine A2A receptor antagonists: from caffeine to selective non-xanthines.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Pierre Matricon; Matthew T Eddy; Jens Carlsson
Journal:  Br J Pharmacol       Date:  2020-06-19       Impact factor: 9.473

9.  Caffeine Supplementation for 4 Days Does Not Induce Tolerance to the Ergogenic Effects Promoted by Acute Intake on Physiological, Metabolic, and Performance Parameters of Cyclists: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study.

Authors:  Anderson Pontes Morales; Felipe Sampaio-Jorge; Thiago Barth; Anna Paola Trindade Rocha Pierucci; Beatriz Gonçalves Ribeiro
Journal:  Nutrients       Date:  2020-07-16       Impact factor: 5.717

Review 10.  The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease.

Authors:  Jiang-Fan Chen; Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2020-03-31       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.